Lundbeck
HLUN-B.CO
#2346
Rank
ยฃ4.97 B
Marketcap
ยฃ5.15
Share price
0.98%
Change (1 day)
18.17%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): ยฃ0.29

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is ยฃ0.27. In 2022 the company made an earnings per share (EPS) of ยฃ0.20 a decrease over its 2021 EPS that were of ยฃ0.46.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.2943.09%
2022ยฃ0.20-55.47%
2021ยฃ0.46-51.83%
2020ยฃ0.96-28.01%
2019ยฃ1.33-44.08%
2018ยฃ2.3751.94%
2017ยฃ1.56126.64%
2016ยฃ0.69-120.84%
2015-ยฃ3.315622.18%
2014-ยฃ0.05780-110.03%
2013ยฃ0.58-28.08%
2012ยฃ0.80-52.1%
2011ยฃ1.67-1.31%
2010ยฃ1.6915.61%
2009ยฃ1.47